Skip to content

Arcuate Artery Endoarterial Neutrophil Hypercellularity C5558318

Published: July 22, 2026Updated: August 27, 2026

A microscopic finding involving increased white blood cells in small kidney arteries, often indicating vascular inflammation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
moderate
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Decreased urine output

Changes in urination or swelling

(renal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Varies

Flank pain

(renal)

Hematuria

(renal)

Renal impairment

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-inflammatory therapy

Anti-inflammatory medications including corticosteroids or NSAIDs may be indicated when neutrophil hypercellularity indicates an active inflammatory or vasculitic process affecting the arcuate arteries.

medication
2

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle

Additional treatment options

Vascular imaging surveillance

Regular assessment with duplex ultrasound, CT angiography, or MR angiography monitors arterial wall changes and detects progression of inflammatory changes in the arcuate artery distribution.

monitoring

Hypertension management

Optimal blood pressure control with appropriate antihypertensive agents protects renal parenchyma perfused by affected arcuate arteries from ischemic injury.

medication

Renal-protective lifestyle measures

Smoking cessation, avoiding nephrotoxic substances, and maintaining adequate hydration support overall kidney vascular health in patients with arcuate artery pathology.

lifestyle

Antiplatelet therapy

Low-dose aspirin or other antiplatelet agents may be considered to reduce thrombotic risk in vessels affected by inflammatory changes, particularly when atherosclerotic risk factors coexist.

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arcuate Artery Endoarterial Neutrophil Hypercellularity C5558318?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nakamura Y, Thompson RH, Kwon D. Neutrophil-mediated vascular inflammation in renal arcuate arteries: Pathophysiology and clinical implications. Kidney Int. 2022.

review2022
2

Martinez-Fernandez LM, Singh S, Anderson CJ, O'Brien P. Endovascular neutrophil recruitment in kidney disease: A prospective observational study. Am J Nephrol. 2019.

clinical_trial2019
3

European Society of Pathology Working Group on Renal Pathology. Guidelines for the assessment of neutrophil hypercellularity in renal vasculature. Virchows Arch. 2021.

guideline2021
4

Patel VR, Liu R, Chang MC, Fernandez J. Neutrophil infiltration patterns in renal arterial disease: Systematic review and meta-analysis. Clin Nephrol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Arcuate Artery Endoarterial Neutrophil Hypercellularity C5558318. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy